Ectonucleotidases in solid organ and allogeneic hematopoietic cell transplantation

Area of Science:

• Immunology
• Biochemistry
• Transplantation Science

Background:

• Extracellular nucleotides act as signaling molecules in physiological and pathological processes.
• Ectonucleotidases regulate extracellular nucleotide levels, impacting inflammation.
• Adenosine, an anti-inflammatory mediator, plays a key role in alloantigen-mediated diseases like graft rejection and GvHD.

Purpose of the Study:

• To investigate the role of ectonucleotidases, specifically NTPDase1/CD39 and ecto-5'-nucleotidase/CD73, in transplantation.
• To analyze the impact of these enzymes on allograft rejection, graft-versus-host disease (GvHD), and graft-versus-leukemia (GvL) effect.
• To explore potential clinical applications of modulating purinergic signaling in post-transplant care.

Main Methods:

• Review of recent studies on ectonucleotidases and purinergic signaling in transplantation.
• Analysis of the balance between pro-inflammatory ATP and anti-inflammatory adenosine.
• Focus on the function of CD39 and CD73 in immune responses post-transplantation.

Main Results:

• Ectonucleotidases significantly influence the balance of extracellular nucleotides, affecting immune responses.
• Adenosine signaling mediated by CD39 and CD73 is crucial in modulating alloimmune responses.
• These enzymes impact graft rejection, GvHD severity, and GvL effects.

Conclusions:

• Ectonucleotidases, particularly CD39 and CD73, are critical regulators of immune responses in transplantation.
• Modulating purinergic signaling offers a promising therapeutic strategy to improve transplant outcomes.
• Targeting ectonucleotidases could mitigate transplant rejection and GvHD while enhancing GvL effects.